Project Grant R34CA293237
- The National Cancer Institute awarded a $222,749 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Rutgers, The State University of New Jersey. The goal of this 5-year grant is to adapt, refine, and pilot test a single-session digital intervention to reduce psychological distress in adolescent siblings of children with cancer. The project will use a community-partnered approach to create an interactive, self-guided intervention that leverages solution-focused brief...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $233,411 to Pennsylvania State University's Milton S. Hershey Medical Center to conduct a randomized controlled trial (RCT) evaluating a narrative communication intervention delivered through digital and mobile technology. The goal is to understand how narrative messaging can influence HPV vaccine decision-making and increase HPV vaccine initiation rates among parents of...
- The federal Project Grant award of $1,187,274.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant is supporting research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida to characterize plant-based phenolic alkanones as next-generation sun protectants for skin cancer prevention. The research project aims to develop novel, plant-derived compounds that can serve as...
- This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $1,116,368 to develop a novel visualization, labeling, and tracking engine for human anatomy to enhance the standardization, precision, and communication of skin cancer data. The project aims to create methods to document reproducible and standardized anatomic site descriptions of skin cancer locations, visualize skin cancer locations, and attach...
- The National Cancer Institute (NCI) awarded a $700,611 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Sloan-Kettering Institute for Cancer Research. The grant, titled "Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)," aims to determine the benefits and barriers to clinical adoption of AI systems for improving melanoma detection and reducing the number of unnecessary biopsies. The project...
- This federal Project Grant award of $635,033, provided by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research program), supports research to understand the genetic basis of a newly recognized cancer-prone syndrome caused by long telomere length. The award was granted to The Johns Hopkins University, a leading federal research contractor, to conduct comprehensive investigations into this genetic mechanism driving cancer development, which is distinct from tumor...
- This $3,355,681 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to evaluate the impact of accessible and scalable digital interventions to address co-occurring insomnia and depression in breast cancer survivors. The project will assess the efficacy of two evidence-based digital interventions, SHUTI and INTELLICARE, in treating these conditions both individually and through an adaptive approach that sequences the interventions based...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $197,414 to Rutgers, The State University of New Jersey to conduct research on "Dyadic and Social Network Influences on Health and Well-Being Among Young Adults with Cancer". The award will support the grantee's training goals over a 5-year period from August 7, 2025 to July 31, 2030. Key objectives include enhancing the grantee's expertise in dyadic functioning of young adult...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $185,693 to the Research Institute at Nationwide Children's Hospital to implement a digital health parent coaching intervention aimed at improving neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The project will be conducted over a 5-year period from March 1, 2025 to February 28, 2030. The Research Institute, a non-profit research...
- The federal Project Grant award of $397,772 was provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research program) to Harvard T.H. Chan School of Public Health. The grant will fund the development of computational methods for profiling the cancer virome and analyzing microbial strain genetics from shotgun metagenomes and metatranscriptomes. This research aims to address key knowledge gaps in understanding the role of viruses and microbial strain variations...
This federal Project Grant award of $861,930, provided by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), will fund a dyadic digital skin cancer prevention intervention for adolescents and their parents. The project aims to develop a scalable digital intervention, utilizing modalities like texting and social media, to promote sun protection behaviors and reduce skin cancer risk among teenagers. The grant was awarded to Rutgers, The State University of New Jersey, to conduct this research over a 3-year period from August 2025 to July 2028. The project seeks to address the gap in prior studies by incorporating both teen and parental influences on sun protection practices, leveraging digital platforms to disseminate the intervention cost-effectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $861.9k | 8/6/25 |